Pyxis Oncology Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PFIZER INC | 02/12/2026 | 7.03 M | $8.09 M | 0.00% | 11.24% |
| LAURION CAPITAL MANAGEMENT LP | 02/17/2026 | 4.80 M | $5.52 M | 32.28% | 7.67% |
| 02/17/2026 | 4.12 M | $4.74 M | 100.00% | 6.59% | |
| VANGUARD GROUP INC | 01/29/2026 | 2.34 M | $2.69 M | 7.94% | 3.73% |
| PALO ALTO INVESTORS LP | 02/17/2026 | 1.04 M | $1.19 M | 0.00% | 1.66% |
| 683 CAPITAL MANAGEMENT, LLC | 02/17/2026 | 891.91 K | $1.03 M | 69.89% | 1.43% |
| JANE STREET GROUP, LLC | 02/12/2026 | 786.01 K | $903.91 K | 158.81% | 1.26% |
| BLACKROCK, INC. | 02/12/2026 | 784.08 K | $901.69 K | 14.68% | 1.25% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 743.11 K | $854.57 K | -8.86% | 1.19% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 728.38 K | $837.64 K | 26.38% | 1.16% |
| HEALTHINVEST PARTNERS AB | 02/06/2026 | 617.25 K | $709.83 K | 100.00% | 0.99% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 587.85 K | $676.03 K | -4.56% | 0.94% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 577.21 K | $664.21 K | 6.01% | 0.92% |
| LONGAEVA PARTNERS L.P. | 02/17/2026 | 503.21 K | $578.70 K | 0.00% | 0.80% |
| UBS GROUP AG | 01/29/2026 | 392.77 K | $451.68 K | 5.09% | 0.63% |
| MARSHALL WACE, LLP | 02/13/2026 | 389.76 K | $448.23 K | 100.00% | 0.62% |
| DECHENG CAPITAL LLC | 02/12/2026 | 326.81 K | $375.83 K | 0.00% | 0.52% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 317.77 K | $365.43 K | 100.00% | 0.51% |
| XTX TOPCO LTD | 02/17/2026 | 289.03 K | $332.39 K | 1,533.05% | 0.46% |
| CITADEL ADVISORS LLC | 02/17/2026 | 243.59 K | $280.13 K | -27.80% | 0.39% |
| STATE STREET CORP | 02/13/2026 | 241.64 K | $277.88 K | 19.59% | 0.39% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 188.14 K | $216.36 K | 100.00% | 0.30% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 183.94 K | $211.53 K | 100.00% | 0.29% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 180.30 K | $207.35 K | 738.60% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 165.04 K | $189.80 K | 0.00% | 0.26% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 145.81 K | $167.69 K | 373.30% | 0.23% |
| NEWEDGE WEALTH, LLC | 02/03/2026 | 116.01 K | $133.41 K | 0.00% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 108.41 K | $124.68 K | -21.17% | 0.17% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 105.53 K | $121.36 K | 126.94% | 0.17% |
| NORTHERN TRUST CORP | 02/17/2026 | 101.95 K | $117.24 K | 1.17% | 0.16% |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 100.54 K | $115.62 K | 100.00% | 0.16% |
| MORGAN STANLEY | 02/13/2026 | 89.22 K | $102.61 K | -16.31% | 0.14% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 86.15 K | $99.07 K | -31.33% | 0.14% |
| CITADEL ADVISORS LLC | 02/17/2026 | 75.50 K | $86.83 K | 100.00% | 0.12% |
| TORONTO DOMINION BANK | 02/17/2026 | 75.00 K | $86.25 K | 100.00% | 0.12% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 72.70 K | $83.61 K | -5.22% | 0.12% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 67.00 K | $77.05 K | 100.00% | 0.11% |
| CABLE CAR CAPITAL LLC | 02/17/2026 | 61.61 K | $70.85 K | 0.00% | 0.10% |
| BARCLAYS PLC | 02/13/2026 | 60.39 K | $69.44 K | 1,939.34% | 0.10% |
| CITADEL ADVISORS LLC | 02/17/2026 | 59.10 K | $67.97 K | 100.00% | 0.09% |
| ROYAL BANK OF CANADA | 02/17/2026 | 55.55 K | $64.00 K | -28.76% | 0.09% |
| 03/23/2026 | 53.00 K | $60.95 K | 100.00% | 0.08% | |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 50.07 K | $57.58 K | 37.11% | 0.08% |
| UNIVERSITY OF CHICAGO | 02/06/2026 | 48.73 K | $56.04 K | 0.00% | 0.08% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/13/2026 | 40.00 K | $46.00 K | -27.27% | 0.06% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/12/2026 | 39.76 K | $45.72 K | -34.99% | 0.06% |
| HRT FINANCIAL LP | 02/12/2026 | 39.65 K | $45.00 K | 157.49% | 0.06% |
| LPL FINANCIAL LLC | 02/11/2026 | 35.10 K | $40.37 K | 150.69% | 0.06% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 31.94 K | $36.73 K | 100.00% | 0.05% |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | 02/17/2026 | 28.86 K | $33.19 K | 100.00% | 0.05% |
Pyxis Oncology Inc institutional Ownership - FAQ's
During the previous two years, 103 institutional investors and hedge funds held shares of Pyxis Oncology Inc. The most heavily invested institutionals were:
UBS Group AG: 254,124
Bank of New York Mellon Corp: 133,996
COMMONWEALTH EQUITY SERVICES, LLC: 34,755
China Universal Asset Management Co., Ltd.: 11,049
Winthrop Capital Management, LLC: 6,000
Mirae Asset Global Investments Co., Ltd.: 3,248
48.27% of Pyxis Oncology Inc stock is owned by institutional investors.
Institutional investors have bought a total of 30.38 M shares in the last 24 months. This purchase volume represents approximately $45.57 M in transactions.